CUMBERLAND PHARMACEUTICALS (CPIX)
US2307701092 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 18.32M | 19.76M | 27.04M | 24.80M | 28.20M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 9.76M | 13.16M | 6.88M | 12.40M | 9.80M | |||
| Inventories | 4.61M | 9.86M | 8.43M | 10.60M | 9.40M | |||
| Other Current Assets | 3.03M | 3.08M | 3.34M | 2.20M | 2.80M | |||
| Total Current Assets | 35.71M | 45.87M | 45.69M | 50.00M | 50.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.04M | 5.50M | 1.47M | 2.60M | 3.70M | |||
| Goodwill | 914.00K | 914.00K | 882.00K | 900.00K | 900.00K | |||
| Intangibles | 22.61M | 30.59M | 23.95M | 28.10M | 30.90M | |||
| Other Non-Current Assets | 15.50M | 10.05M | 12.47M | 14.90M | 18.90M | |||
| Total Non-Current Assets | 46.06M | 47.05M | 38.77M | 46.50M | 54.30M | |||
| TOTAL ASSETS | 81.78M | 92.93M | 84.46M | 96.50M | 104.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 1.55M | 2.22M | 2.33M | 2.30M | 3.00M | |||
| Accounts Payable | 14.04M | 10.82M | 9.64M | 13.40M | 11.90M | |||
| Other Current Liabilities | 12.40M | 15.54M | 7.31M | 10.00M | 9.20M | |||
| Total Current Liabilities | 27.98M | 28.58M | 19.28M | 25.70M | 24.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 12.78M | 16.20M | 15.00M | 15.00M | 18.50M | |||
| Other Non-Current Liabilities | 11.75M | 12.17M | 7.58M | 8.90M | 10.80M | |||
| Total Non-Current Liabilities | 24.19M | 28.08M | 22.37M | 23.80M | 29.20M | |||
| TOTAL LIABILITIES | 52.17M | 56.66M | 41.65M | 49.50M | 53.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -17.49M | -11.21M | -5.64M | -2.10M | 1.20M | |||
| Minority Interest | -292.12K | -212.33K | -117.12K | -20.00K | 10.00K | |||
| Common Shares | 47.09M | 47.47M | 48.45M | 49.10M | 49.90M | |||
| Shares Outstanding | 14.12M | 14.37M | 14.74M | 15.00M | 15.30M | |||
| Tangible Book Value per Share | 0.43 | 0.33 | 1.22 | 1.20 | 1.26 | |||
| Total Shareholders' Equity | 29.60M | 36.27M | 42.81M | 47.00M | 51.10M | |||
| TOTAL LIABILITIES AND EQUITY | 81.78M | 92.93M | 84.46M | 96.50M | 104.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.43 | 0.45 | 0.35 | 0.32 | 0.36 | |||
| Current Ratio | 1.28 | 1.60 | 2.37 | 1.95 | 2.07 | |||
| Return On Assets (ROA) | -7.68% | -5.99% | -4.15% | -3.46% | -3.39% | |||
| Return On Equity (ROE) | -21.21% | -15.36% | -8.19% | -7.11% | -6.93% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD